73
Views
3
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Malondialdehyde and C-reactive protein as prognostic markers of hepatocellular carcinoma

, ORCID Icon, ORCID Icon, ORCID Icon, , , , & show all
Pages 94-96 | Received 13 Oct 2019, Accepted 08 Jan 2020, Published online: 25 Feb 2020

References

  • Attallah AM, Omran D, Marie MS. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. Br J Biomed Sci. 2018;75:157–162.
  • Arafa M, Besheer T, El-Eraky AM. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients. Br J Biomed Sci. 2019;76:64–69.
  • Lorente L, Rodriguez ST, Sanz P, et al. Association between pre-transplant serum malondialdehyde levels and survival one year after liver transplantation for hepatocellular carcinoma. Int J Mol Sci. 2016;17:500.
  • Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res. 1999;424:83–95.
  • Hashimoto K, Ikeda Y, Korenaga D, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer. 2005;103:1856–1864.
  • Shiha G, Elagroudy O, Shef S, et al. MicroRNA 122 as a diagnostic biomarker for hepatitis C- related hepatocellular carcinoma. Med J Viral Hepatitis.2019;4:35–43.
  • Elsaadawy S, Elbadawy R, Abd Elaziz B, et al. The effect of melatonin on apoptosis in hepatocellular carcinoma cell line: an experimental study. Med J Viral Hepatitis.2019;4:75–79.
  • Abdel-Razik A, Mousa N, Rania Elhelaly R, et al. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for end-stage liver disease scoring system. Eur J Gastroenterol Hepatol. 2015;27:585–592.
  • Alfar M, Abd El-Maksoud M, Mousa N. B-cell monoclonal lymphocytosis in chronic hepatitis C virus infection. Med J Viral Hepatitis. 2018;3:27–35.
  • Czeczot H, Scibior D, Skrzycki M, et al. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol. 2006;53:237–241.
  • Elalfy H, Besheer T, El-Maksoud M, et al. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization. Br J Biomed Sci. 2018;75:187–191.
  • Lin ZY, Wang LY, Yu ML, et al. Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis. J Gastroenterol Hepatol. 2000;15:417–421.
  • O’Hanlon DM, Lynch J, Cormican M, et al. The acute phase response in breast carcinoma. Anticancer Res. 2002 Mar–Apr;22(2B);221289–221293.
  • Alexandrakis MG, Passam FH, Moschandrea IA, et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol. 2003;26:135–140.
  • Jabs WJ, Busse M, Kruger S, et al. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int. 2005;68:2103–2110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.